The first study on cases in the current UK monkeypox outbreak reports important differences in patient's symptoms to those observed in previous outbreaks elsewhere in the world. The study, published in The Lancet Infectious ...
Jul 1, 2022
0
46
COVID-19 vaccines reduced the potential global death toll during the pandemic by more than half in the year following their implementation, a mathematical modeling study published today in The Lancet Infectious Diseases estimates.
Jun 23, 2022
0
35
A new retrospective study of seven patients diagnosed with monkeypox in the UK between 2018 and 2021, suggests that some antiviral medications might have the potential to shorten symptoms and reduce the amount of time a patient ...
May 25, 2022
0
9
As headlines focus on COVID-19, and now monkeypox, tuberculosis remains one of the great scourges of infectious disease around the world. Approximately 1.5 million people died of tuberculosis in 2020, the World Health Organization ...
May 23, 2022
0
3
A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalized.
May 16, 2022
0
126
A vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) was found to be safe, well-tolerated and induced a neutralizing antibody response ...
May 12, 2022
0
7
Meningitis vaccines could help improve protection against gonorrhea amid rising cases globally and increasing bacterial resistance to drugs used to treat the infection, according to findings from three linked papers published ...
Apr 13, 2022
0
28
People who have recovered from COVID-19 still benefit from vaccination, according to a new study led by a Stanford Medicine researcher and colleagues in Brazil.
Apr 6, 2022
0
30
People with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against the virus, two new studies said on Friday.
Apr 1, 2022
0
207
Late last year, preliminary studies revealed that the fast-spreading omicron SARS-CoV-2 variant was likely to evade COVID-19 antibodies but, in many people, less so than expected. Now one of those studies from Karolinska ...
Mar 18, 2022
0
72
